Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
10 Mar 22
Current reports
8-K
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
7 Mar 24
8-K
Departure of Directors or Certain Officers
4 Jan 24
8-K
Regulation FD Disclosure
11 Dec 23
8-K
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
9 Nov 23
8-K
Departure of Directors or Certain Officers
10 Oct 23
8-K
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023
8 Aug 23
8-K
Astellas and Poseida Therapeutics Announce Strategic
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Termination of a Material Definitive Agreement
1 Jun 23
8-K
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023
9 May 23
Registration and prospectus
S-8
Registration of securities for employees
8 Feb 24
D
$25.00 mm in equity, sold $25.00 mm, 1 investor
11 Aug 23
S-8
Registration of securities for employees
12 Jan 23
424B5
Prospectus supplement for primary offering
4 Aug 22
424B5
Prospectus supplement for primary offering
3 Aug 22
S-8
Registration of securities for employees
18 Feb 22
S-3
Shelf registration
13 Aug 21
S-8
Registration of securities for employees
8 Jun 21
S-8
Registration of securities for employees
23 Jul 20
424B4
Prospectus supplement with pricing info
10 Jul 20
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
25 May 22
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
Other
UPLOAD
Letter from SEC
17 Jul 23
CORRESP
Correspondence with SEC
7 Jul 23
UPLOAD
Letter from SEC
22 Jun 23
EFFECT
Notice of effectiveness
23 Aug 21
CORRESP
Correspondence with SEC
18 Aug 21
UPLOAD
Letter from SEC
18 Aug 21
EFFECT
Notice of effectiveness
10 Jul 20
CERT
Certification of approval for exchange listing
9 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20
CORRESP
Correspondence with SEC
7 Jul 20